South Africa

South Africa

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.51 (3.07 - 3.93) 2019 Modelled IHME
3.5 (3.05 - 3.92) 2018 Modelled IHME
3.5 (3.05 - 3.92) 2017 Modelled IHME
3.5 (3.07 - 3.92) 2016 Modelled IHME
3.52 (3.08 - 3.95) 2015 Modelled IHME
3.57 (3.13 - 4) 2014 Modelled IHME
3.66 (3.22 - 4.07) 2013 Modelled IHME
3.78 (3.33 - 4.19) 2012 Modelled IHME
3.91 (3.46 - 4.34) 2011 Modelled IHME
4.04 (3.58 - 4.48) 2010 Modelled IHME
4.17 (3.70 - 4.63) 2009 Modelled IHME
4.32 (3.85 - 4.79) 2008 Modelled IHME
4.48 (3.98 - 4.98) 2007 Modelled IHME
4.63 (4.11 - 5.16) 2006 Modelled IHME
4.79 (4.24 - 5.35) 2005 Modelled IHME
4.94 (4.37 - 5.53) 2004 Modelled IHME
5.09 (4.49 - 5.69) 2003 Modelled IHME
5.25 (4.60 - 5.86) 2002 Modelled IHME
5.4 (4.72 - 6.04) 2001 Modelled IHME
5.54 (4.82 - 6.21) 2000 Modelled IHME
5.69 (4.97 - 6.38) 1999 Modelled IHME
5.83 (5.08 - 6.55) 1998 Modelled IHME
5.97 (5.19 - 6.72) 1997 Modelled IHME
6.1 (5.30 - 6.88) 1996 Modelled IHME
6.22 (5.41 - 7.04) 1995 Modelled IHME
6.34 (5.51 - 7.14) 1994 Modelled IHME
6.45 (5.61 - 7.28) 1993 Modelled IHME
6.55 (5.71 - 7.39) 1992 Modelled IHME
6.65 (5.79 - 7.53) 1991 Modelled IHME
6.74 (5.88 - 7.65) 1990 Modelled IHME
3.53 (2.59 - 4.77) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
1.97 (1.63 - 2.33) 2019 Modelled IHME
1.99 (1.64 - 2.37) 2018 Modelled IHME
1.99 (1.64 - 2.37) 2017 Modelled IHME
1.99 (1.65 - 2.36) 2016 Modelled IHME
1.98 (1.64 - 2.35) 2015 Modelled IHME
2.01 (1.67 - 2.38) 2014 Modelled IHME
2.09 (1.73 - 2.47) 2013 Modelled IHME
2.18 (1.83 - 2.58) 2012 Modelled IHME
2.26 (1.89 - 2.67) 2011 Modelled IHME
2.3 (1.91 - 2.71) 2010 Modelled IHME
2.3 (1.91 - 2.72) 2009 Modelled IHME
2.3 (1.92 - 2.73) 2008 Modelled IHME
2.31 (1.92 - 2.72) 2007 Modelled IHME
2.31 (1.92 - 2.71) 2006 Modelled IHME
2.31 (1.90 - 2.72) 2005 Modelled IHME
2.37 (1.96 - 2.79) 2004 Modelled IHME
2.49 (2.06 - 2.93) 2003 Modelled IHME
2.64 (2.17 - 3.10) 2002 Modelled IHME
2.76 (2.26 - 3.25) 2001 Modelled IHME
2.81 (2.29 - 3.32) 2000 Modelled IHME
2.76 (2.27 - 3.26) 1999 Modelled IHME
2.66 (2.19 - 3.14) 1998 Modelled IHME
2.53 (2.08 - 2.98) 1997 Modelled IHME
2.42 (2 - 2.85) 1996 Modelled IHME
2.38 (1.96 - 2.80) 1995 Modelled IHME
2.61 (2.16 - 3.07) 1994 Modelled IHME
3.24 (2.69 - 3.82) 1993 Modelled IHME
4.18 (3.48 - 4.93) 1992 Modelled IHME
5.34 (4.45 - 6.32) 1991 Modelled IHME
6.62 (5.52 - 7.86) 1990 Modelled IHME
1.74 (1.23 - 2.35) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
4 (3.48 - 4.54) 2019 Modelled IHME
3.95 (3.47 - 4.49) 2018 Modelled IHME
3.96 (3.49 - 4.47) 2017 Modelled IHME
3.95 (3.51 - 4.44) 2016 Modelled IHME
4.1 (3.66 - 4.59) 2015 Modelled IHME
4.18 (3.75 - 4.63) 2014 Modelled IHME
4.2 (3.77 - 4.67) 2013 Modelled IHME
4.3 (3.87 - 4.76) 2012 Modelled IHME
4.45 (4.03 - 4.90) 2011 Modelled IHME
4.74 (4.29 - 5.24) 2010 Modelled IHME
4.91 (4.44 - 5.46) 2009 Modelled IHME
5.03 (4.52 - 5.64) 2008 Modelled IHME
5.14 (4.61 - 5.77) 2007 Modelled IHME
5.36 (4.78 - 6.03) 2006 Modelled IHME
5.36 (4.80 - 6) 2005 Modelled IHME
5.6 (5.06 - 6.25) 2004 Modelled IHME
5.97 (5.37 - 6.62) 2003 Modelled IHME
6.29 (5.68 - 6.92) 2002 Modelled IHME
6.58 (5.95 - 7.21) 2001 Modelled IHME
6.8 (6.18 - 7.45) 2000 Modelled IHME
6.59 (5.89 - 7.22) 1999 Modelled IHME
6.66 (5.97 - 7.31) 1998 Modelled IHME
6.39 (5.62 - 7.06) 1997 Modelled IHME
5.79 (4.85 - 6.78) 1996 Modelled IHME
5.57 (4.60 - 6.71) 1995 Modelled IHME
5.47 (4.43 - 6.78) 1994 Modelled IHME
5.28 (4.20 - 6.67) 1993 Modelled IHME
5.48 (4.44 - 6.85) 1992 Modelled IHME
5.37 (4.20 - 6.92) 1991 Modelled IHME
5.46 (4.18 - 7.18) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
2,224 (1,933 - 2,521) 2019 Modelled IHME
2,176 (1,910 - 2,473) 2018 Modelled IHME
2,159 (1,902 - 2,436) 2017 Modelled IHME
2,133 (1,896 - 2,396) 2016 Modelled IHME
2,192 (1,956 - 2,451) 2015 Modelled IHME
2,213 (1,985 - 2,450) 2014 Modelled IHME
2,198 (1,975 - 2,444) 2013 Modelled IHME
2,226 (2,006 - 2,465) 2012 Modelled IHME
2,280 (2,066 - 2,509) 2011 Modelled IHME
2,402 (2,175 - 2,660) 2010 Modelled IHME
2,469 (2,232 - 2,746) 2009 Modelled IHME
2,502 (2,251 - 2,810) 2008 Modelled IHME
2,537 (2,277 - 2,847) 2007 Modelled IHME
2,621 (2,339 - 2,949) 2006 Modelled IHME
2,599 (2,329 - 2,908) 2005 Modelled IHME
2,687 (2,426 - 3,001) 2004 Modelled IHME
2,834 (2,548 - 3,141) 2003 Modelled IHME
2,947 (2,663 - 3,243) 2002 Modelled IHME
3,039 (2,751 - 3,331) 2001 Modelled IHME
3,095 (2,811 - 3,390) 2000 Modelled IHME
2,942 (2,629 - 3,224) 1999 Modelled IHME
2,919 (2,618 - 3,205) 1998 Modelled IHME
2,744 (2,415 - 3,035) 1997 Modelled IHME
2,434 (2,040 - 2,853) 1996 Modelled IHME
2,292 (1,894 - 2,760) 1995 Modelled IHME
2,201 (1,785 - 2,732) 1994 Modelled IHME
2,078 (1,653 - 2,627) 1993 Modelled IHME
2,112 (1,711 - 2,636) 1992 Modelled IHME
2,023 (1,584 - 2,607) 1991 Modelled IHME
2,010 (1,538 - 2,644) 1990 Modelled IHME
2,064 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
36 (32 - 41) 2019 Modelled IHME
36 (32 - 40) 2018 Modelled IHME
35 (31 - 40) 2017 Modelled IHME
35 (31 - 40) 2016 Modelled IHME
36 (32 - 40) 2015 Modelled IHME
36 (32 - 40) 2014 Modelled IHME
36 (32 - 40) 2013 Modelled IHME
36 (32 - 40) 2012 Modelled IHME
36 (33 - 40) 2011 Modelled IHME
37 (33 - 41) 2010 Modelled IHME
37 (33 - 41) 2009 Modelled IHME
37 (34 - 41) 2008 Modelled IHME
38 (34 - 41) 2007 Modelled IHME
38 (34 - 42) 2006 Modelled IHME
38 (34 - 42) 2005 Modelled IHME
38 (34 - 42) 2004 Modelled IHME
38 (34 - 42) 2003 Modelled IHME
38 (34 - 42) 2002 Modelled IHME
38 (34 - 42) 2001 Modelled IHME
38 (34 - 42) 2000 Modelled IHME
37 (34 - 41) 1999 Modelled IHME
37 (33 - 41) 1998 Modelled IHME
36 (33 - 40) 1997 Modelled IHME
36 (32 - 40) 1996 Modelled IHME
37 (33 - 40) 1995 Modelled IHME
36 (32 - 41) 1994 Modelled IHME
37 (32 - 41) 1993 Modelled IHME
37 (33 - 41) 1992 Modelled IHME
37 (33 - 41) 1991 Modelled IHME
37 (33 - 42) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
74 2018 Survey/reported WHO/UNICEF
76 2017 Survey/reported WHO/UNICEF
76 2016 Survey/reported WHO/UNICEF
85 2015 Survey/reported WHO/UNICEF
85 2014 Survey/reported WHO/UNICEF
73 2013 Survey/reported WHO/UNICEF
70 2012 Survey/reported WHO/UNICEF
76 2011 Survey/reported WHO/UNICEF
71 2010 Survey/reported WHO/UNICEF
74 2009 Survey/reported WHO/UNICEF
76 2008 Survey/reported WHO/UNICEF
83 2007 Survey/reported WHO/UNICEF
83 2006 Survey/reported WHO/UNICEF
79 2005 Survey/reported WHO/UNICEF
76 2004 Survey/reported WHO/UNICEF
71 2003 Survey/reported WHO/UNICEF
72 2002 Survey/reported WHO/UNICEF
72 2001 Survey/reported WHO/UNICEF
73 2000 Survey/reported WHO/UNICEF
73 1999 Survey/reported WHO/UNICEF
74 1998 Survey/reported WHO/UNICEF
74 1997 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
9 (3 - 31) 2016 Survey/reported Larney S et al, 2017

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
11.3 (8.60 - 14.60) 2013 Survey/reported Scheibe A et al, 2015
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Risk-based
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.56 (1.26 - 1.95) 2019 Modelled IHME
1.55 (1.25 - 1.94) 2018 Modelled IHME
1.54 (1.23 - 1.93) 2017 Modelled IHME
1.52 (1.22 - 1.90) 2016 Modelled IHME
1.51 (1.21 - 1.88) 2015 Modelled IHME
1.52 (1.22 - 1.91) 2014 Modelled IHME
1.55 (1.24 - 1.94) 2013 Modelled IHME
1.58 (1.27 - 1.99) 2012 Modelled IHME
1.61 (1.29 - 2.04) 2011 Modelled IHME
1.62 (1.30 - 2.05) 2010 Modelled IHME
1.61 (1.29 - 2.04) 2009 Modelled IHME
1.59 (1.27 - 2) 2008 Modelled IHME
1.57 (1.25 - 1.96) 2007 Modelled IHME
1.54 (1.23 - 1.93) 2006 Modelled IHME
1.53 (1.23 - 1.91) 2005 Modelled IHME
1.53 (1.22 - 1.90) 2004 Modelled IHME
1.52 (1.22 - 1.90) 2003 Modelled IHME
1.52 (1.21 - 1.90) 2002 Modelled IHME
1.52 (1.21 - 1.89) 2001 Modelled IHME
1.51 (1.21 - 1.89) 2000 Modelled IHME
1.49 (1.20 - 1.87) 1999 Modelled IHME
1.46 (1.17 - 1.83) 1998 Modelled IHME
1.43 (1.14 - 1.79) 1997 Modelled IHME
1.4 (1.12 - 1.75) 1996 Modelled IHME
1.39 (1.11 - 1.74) 1995 Modelled IHME
1.39 (1.11 - 1.75) 1994 Modelled IHME
1.4 (1.12 - 1.76) 1993 Modelled IHME
1.41 (1.13 - 1.78) 1992 Modelled IHME
1.43 (1.14 - 1.81) 1991 Modelled IHME
1.46 (1.16 - 1.85) 1990 Modelled IHME
0.7 (0.40 - 0.90) 2015 Modelled Blach et al, 2017
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.7 (1 - 2.50) 2014 Modelled Gower et al, 2014

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.25 (3.72 - 4.86) 2019 Modelled IHME
4.22 (3.72 - 4.77) 2018 Modelled IHME
4.29 (3.81 - 4.86) 2017 Modelled IHME
4.3 (3.84 - 4.91) 2016 Modelled IHME
4.43 (3.95 - 5.04) 2015 Modelled IHME
4.48 (4.02 - 5.04) 2014 Modelled IHME
4.47 (4 - 5.03) 2013 Modelled IHME
4.55 (4.09 - 5.10) 2012 Modelled IHME
4.69 (4.22 - 5.26) 2011 Modelled IHME
4.96 (4.47 - 5.55) 2010 Modelled IHME
5.14 (4.62 - 5.79) 2009 Modelled IHME
5.26 (4.71 - 5.92) 2008 Modelled IHME
5.39 (4.83 - 6.04) 2007 Modelled IHME
5.61 (4.99 - 6.34) 2006 Modelled IHME
5.6 (5.01 - 6.28) 2005 Modelled IHME
5.66 (5.08 - 6.33) 2004 Modelled IHME
5.64 (5.07 - 6.29) 2003 Modelled IHME
5.55 (5.02 - 6.15) 2002 Modelled IHME
5.52 (4.98 - 6.13) 2001 Modelled IHME
5.6 (5.03 - 6.24) 2000 Modelled IHME
5.48 (4.86 - 6.08) 1999 Modelled IHME
5.61 (5 - 6.20) 1998 Modelled IHME
5.46 (4.80 - 6.13) 1997 Modelled IHME
4.98 (4.17 - 5.82) 1996 Modelled IHME
4.78 (3.87 - 5.73) 1995 Modelled IHME
4.69 (3.78 - 5.63) 1994 Modelled IHME
4.46 (3.52 - 5.49) 1993 Modelled IHME
4.54 (3.63 - 5.47) 1992 Modelled IHME
4.33 (3.37 - 5.34) 1991 Modelled IHME
4.24 (3.30 - 5.34) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
2,363 (2,065 - 2,699) 2019 Modelled IHME
2,323 (2,049 - 2,628) 2018 Modelled IHME
2,339 (2,078 - 2,651) 2017 Modelled IHME
2,324 (2,071 - 2,654) 2016 Modelled IHME
2,369 (2,113 - 2,695) 2015 Modelled IHME
2,369 (2,128 - 2,666) 2014 Modelled IHME
2,337 (2,092 - 2,631) 2013 Modelled IHME
2,353 (2,116 - 2,639) 2012 Modelled IHME
2,403 (2,161 - 2,695) 2011 Modelled IHME
2,517 (2,267 - 2,816) 2010 Modelled IHME
2,583 (2,323 - 2,912) 2009 Modelled IHME
2,619 (2,346 - 2,948) 2008 Modelled IHME
2,659 (2,385 - 2,983) 2007 Modelled IHME
2,745 (2,441 - 3,104) 2006 Modelled IHME
2,713 (2,428 - 3,043) 2005 Modelled IHME
2,714 (2,440 - 3,037) 2004 Modelled IHME
2,679 (2,408 - 2,988) 2003 Modelled IHME
2,600 (2,354 - 2,881) 2002 Modelled IHME
2,549 (2,302 - 2,830) 2001 Modelled IHME
2,548 (2,286 - 2,836) 2000 Modelled IHME
2,447 (2,170 - 2,714) 1999 Modelled IHME
2,458 (2,192 - 2,716) 1998 Modelled IHME
2,346 (2,062 - 2,633) 1997 Modelled IHME
2,094 (1,753 - 2,447) 1996 Modelled IHME
1,969 (1,593 - 2,359) 1995 Modelled IHME
1,887 (1,522 - 2,269) 1994 Modelled IHME
1,758 (1,387 - 2,162) 1993 Modelled IHME
1,747 (1,397 - 2,107) 1992 Modelled IHME
1,630 (1,268 - 2,010) 1991 Modelled IHME
1,563 (1,216 - 1,967) 1990 Modelled IHME
1,530 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
26 (23 - 29) 2019 Modelled IHME
26 (23 - 29) 2018 Modelled IHME
27 (23 - 30) 2017 Modelled IHME
27 (24 - 30) 2016 Modelled IHME
27 (24 - 30) 2015 Modelled IHME
27 (24 - 29) 2014 Modelled IHME
27 (24 - 29) 2013 Modelled IHME
26 (24 - 29) 2012 Modelled IHME
26 (24 - 29) 2011 Modelled IHME
26 (23 - 29) 2010 Modelled IHME
26 (23 - 28) 2009 Modelled IHME
25 (23 - 28) 2008 Modelled IHME
25 (23 - 28) 2007 Modelled IHME
25 (22 - 28) 2006 Modelled IHME
25 (22 - 27) 2005 Modelled IHME
25 (22 - 27) 2004 Modelled IHME
25 (22 - 27) 2003 Modelled IHME
25 (22 - 27) 2002 Modelled IHME
25 (22 - 27) 2001 Modelled IHME
25 (22 - 27) 2000 Modelled IHME
25 (23 - 28) 1999 Modelled IHME
26 (23 - 28) 1998 Modelled IHME
26 (23 - 29) 1997 Modelled IHME
26 (23 - 30) 1996 Modelled IHME
26 (23 - 30) 1995 Modelled IHME
27 (23 - 31) 1994 Modelled IHME
27 (22 - 31) 1993 Modelled IHME
27 (22 - 31) 1992 Modelled IHME
27 (22 - 31) 1991 Modelled IHME
27 (22 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
9 (3 - 31) 2016 Survey/reported Larney S et al, 2017

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
11.3 (8.60 - 14.60) 2013 Survey/reported Scheibe A et al, 2015
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Risk-based
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
2,224
2019
(1,933 - 2,521)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
2,363
2019
(2,065 - 2,699)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
9
2016
(3 - 31)
Larney S et al, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines